PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Ductal Carcinoma In Situ Discovery from Gynecomastia Surgery by Dr Ivan Puah
2025-08-06T    Health Care/Hospital   Medical/Pharmaceuticals 
Ductal Carcinoma In Situ Discovery from Gynecomastia Surgery by Dr Ivan Puah
2025-08-06T    Health Care/Hospital   Medical/Pharmaceuticals 
Everest Medicines Announces Full Approval of NEFECON® in Taiwan
2025-08-06T    Health Care/Hospital   Medical/Pharmaceuticals 
From AI to Precision Medicine: Taiwan's Smart Healthcare Innovations Shine at Taiwan Expo USA 2025
2025-08-06T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency
2025-08-06T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year
2025-08-06T    Biotechnology   Environmental Products & Services   Health Care/Hospital   Medical/Pharmaceuticals 
Sanyou Bio Wins the "2025 Best Customer Satisfaction CRO Award"
2025-08-05T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics
2025-08-05T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
FigureLabs: World's First AI scientific illustration tool for Effortless Publication Figures
2025-08-05T    Computer Software   Computer/Electronics   Medical/Pharmaceuticals   Multimedia/Online/Internet 
Neopharma Technologies Appoints Exchange Listing to Manage U.S. IPO
2025-08-05T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.